Mahar Pir Salim, Monis Mohammad Daniyal, Khan Muhammad Fahadullah, Ahsan Shahid, Memon M Saleh
Ophthalmology, Isra Postgraduate Institute of Ophthalmology, Karachi, PAK.
Ophthalmology, Aga Khan University Hospital, Karachi, PAK.
Cureus. 2024 Sep 12;16(9):e69296. doi: 10.7759/cureus.69296. eCollection 2024 Sep.
The objective of this study is to evaluate diabetic patients with either normal fundus or non-proliferative diabetic retinopathy (NPDR) changes, examine retinal alterations during follow-up, and propose follow-up guidelines within a tertiary eye care setting.
A five-year prospective longitudinal study is being conducted at the Diabetic Clinic of Al Ibrahim Eye Hospital/Isra Postgraduate Institute of Ophthalmology, Karachi. Induction for the research took place from October 2021 to March 2022, and a two-year preliminary report is presented here. Newly diagnosed type II diabetic patients with normal fundus or NPDR of any stage, irrespective of age, gender, or glycemic status, who were willing to participate and agreed to follow-ups, were included. Patients with proliferative diabetic retinopathy (PDR), diabetic macular edema (DME), fundus non-visibility, or systemic complications of diabetes were excluded.
A total of 251 patients were enrolled, consisting of 80 individuals with a normal fundus and 171 with different stages of NPDR, including mild (N=59), moderate (N=91), and severe (N=21) retinopathy. The incidence of progression from mild to moderate NPDR was noted to be 52.5%, with a median time of 3.5 months. Progression from moderate to severe NPDR occurred in 37.1% of cases, with a median time of 4.5 months. Similarly, DME developed in 5% of patients with mild NPDR over eight months, in 22.2% with moderate NPDR over seven months, and in 37.5% with severe NPDR over 4.4 months.
This study emphasizes the urgent need to revise diabetic retinopathy (DR) monitoring protocols for our Pakistani (Southeast Asian) population. The rapid progression of NPDR and the high rates of DME development demand more frequent screenings. Current guidelines recommending annual screenings are inadequate. Biannual screenings for patients with a normal fundus or mild NPDR, and quarterly assessments for those with moderate or severe NPDR, are necessary.
本研究的目的是评估眼底正常或患有非增殖性糖尿病视网膜病变(NPDR)的糖尿病患者,观察随访期间的视网膜变化,并在三级眼科护理机构中提出随访指南。
在卡拉奇的易卜拉欣眼科医院/伊斯兰州立眼科研究生学院糖尿病诊所进行了一项为期五年的前瞻性纵向研究。研究于2021年10月至2022年3月开展,此处呈现一份为期两年的初步报告。纳入新诊断的眼底正常或处于任何阶段NPDR的II型糖尿病患者,不限年龄、性别或血糖状态,且愿意参与并同意随访。排除患有增殖性糖尿病视网膜病变(PDR)、糖尿病性黄斑水肿(DME)、眼底不可见或糖尿病全身性并发症的患者。
共纳入251例患者,其中80例眼底正常,171例处于不同阶段的NPDR,包括轻度(N = 59)、中度(N = 91)和重度(N = 21)视网膜病变。从轻度NPDR进展为中度NPDR的发生率为52.5%,中位时间为3.5个月。37.1%的病例从中度NPDR进展为重度NPDR,中位时间为4.5个月。同样,轻度NPDR患者中有5%在8个月内发生DME,中度NPDR患者中有22.2%在7个月内发生DME,重度NPDR患者中有37.5%在4.4个月内发生DME。
本研究强调迫切需要为我们的巴基斯坦(东南亚)人群修订糖尿病视网膜病变(DR)监测方案。NPDR的快速进展和DME的高发生率需要更频繁的筛查。目前建议每年进行筛查的指南并不充分。对于眼底正常或轻度NPDR的患者,每半年进行一次筛查,对于中度或重度NPDR的患者,每季度进行一次评估是必要的。